Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Chan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Organic Letters|August 28, 2004
Polytriazoles as copper(I)-stabilizing ligands in catalysisTimothy R Chan, Robert Hilgraf, K Barry Sharpless, et al.
Journal of the American Chemical Society|March 13, 2003
Bioconjugation by copper(I)-catalyzed azide-alkyne [3 + 2] cycloadditionQian Wang, Timothy R Chan, Robert Hilgraf, et al.
The European Journal of Neuroscience|April 10, 2014
Synapto-depressive effects of amyloid beta require PICK1Stephanie Alfonso, Helmut W Kessels, Charles C Banos, et al.
Journal of Medicinal Chemistry|July 23, 2020
Discovery of BIIB068: A Selective, Potent, Reversible Bruton's Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune DiseasesBin Ma, Tonika Bohnert, Kevin L Otipoby, et al.
Scientific Reports|September 9, 2018
Potent PDZ-Domain PICK1 Inhibitors that Modulate Amyloid Beta-Mediated Synaptic DysfunctionEdward Y S Lin, Laura F Silvian, Douglas J Marcotte, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Organic Letters|August 28, 2004
Polytriazoles as copper(I)-stabilizing ligands in catalysisTimothy R Chan, Robert Hilgraf, K Barry Sharpless, et al.
Journal of the American Chemical Society|March 13, 2003
Bioconjugation by copper(I)-catalyzed azide-alkyne [3 + 2] cycloadditionQian Wang, Timothy R Chan, Robert Hilgraf, et al.
The European Journal of Neuroscience|April 10, 2014
Synapto-depressive effects of amyloid beta require PICK1Stephanie Alfonso, Helmut W Kessels, Charles C Banos, et al.
Journal of Medicinal Chemistry|July 23, 2020
Discovery of BIIB068: A Selective, Potent, Reversible Bruton's Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune DiseasesBin Ma, Tonika Bohnert, Kevin L Otipoby, et al.
Scientific Reports|September 9, 2018
Potent PDZ-Domain PICK1 Inhibitors that Modulate Amyloid Beta-Mediated Synaptic DysfunctionEdward Y S Lin, Laura F Silvian, Douglas J Marcotte, et al.
Pageof 1